Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Pro Dex (PDEX) over the last 12 years, with Q4 2025 value amounting to $8.0 million.

  • Pro Dex's Cash & Equivalents rose 1195000.0% to $8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.0 million, marking a year-over-year increase of 1195000.0%. This contributed to the annual value of $6.9 million for FY2025, which is 1881.55% up from last year.
  • Latest data reveals that Pro Dex reported Cash & Equivalents of $8.0 million as of Q4 2025, which was up 1195000.0% from $10.2 million recorded in Q3 2025.
  • In the past 5 years, Pro Dex's Cash & Equivalents ranged from a high of $10.2 million in Q3 2025 and a low of $66000.0 during Q4 2024
  • In the last 5 years, Pro Dex's Cash & Equivalents had a median value of $3.2 million in 2024 and averaged $3.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9487.98% in 2024, then surged by 1195000.0% in 2025.
  • Pro Dex's Cash & Equivalents (Quarter) stood at $5.3 million in 2021, then crashed by 92.73% to $382000.0 in 2022, then soared by 237.43% to $1.3 million in 2023, then plummeted by 94.88% to $66000.0 in 2024, then soared by 11950.0% to $8.0 million in 2025.
  • Its Cash & Equivalents stands at $8.0 million for Q4 2025, versus $10.2 million for Q3 2025 and $6.9 million for Q2 2025.